These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2918461

  • 1. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma.
    Aboulafia D, Miles SA, Saks SR, Mitsuyasu RT.
    J Acquir Immune Defic Syndr (1988); 1989; 2(1):54-8. PubMed ID: 2918461
    [Abstract] [Full Text] [Related]

  • 2. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM.
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [Abstract] [Full Text] [Related]

  • 3. Intralesional recombinant tumor necrosis factor-alpha for AIDS-associated Kaposi's sarcoma: a randomized, double-blind trial.
    Kahn JO, Kaplan LD, Volberding PA, Ziegler JL, Crowe S, Saks SR, Abrams DI.
    J Acquir Immune Defic Syndr (1988); 1989; 2(3):217-23. PubMed ID: 2498507
    [Abstract] [Full Text] [Related]

  • 4. Clinical aspects of AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT.
    Curr Opin Oncol; 1993 Sep; 5(5):835-44. PubMed ID: 8218496
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
    Pellet C, Chevret S, Blum L, Gauvillé C, Hurault M, Blanchard G, Agbalika F, Lascoux C, Ponscarme D, Morel P, Calvo F, Lebbé C.
    J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
    Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS.
    Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
    Evans LM, Itri LM, Campion M, Wyler-Plaut R, Krown SE, Groopman JE, Goldsweig H, Volberding PA, West SB, Mitsuyasu RT.
    J Immunother (1991); 1991 Feb; 10(1):39-50. PubMed ID: 1826454
    [Abstract] [Full Text] [Related]

  • 12. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
    Mitsuyasu RT.
    Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
    [Abstract] [Full Text] [Related]

  • 13. Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome.
    Groopman JE, Gottlieb MS, Goodman J, Mitsuyasu RT, Conant MA, Prince H, Fahey JL, Derezin M, Weinstein WM, Casavante C.
    Ann Intern Med; 1984 May; 100(5):671-6. PubMed ID: 6712031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Aetiology of Kaposi's sarcoma: current understanding and implications for therapy.
    Boshoff C, Weiss RA.
    Mol Med Today; 1997 Nov; 3(11):488-94. PubMed ID: 9430784
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.